PJP (PJP) Stock Price & Analysis
PJP (PJP) rose 1.41% to USD 112 as of June 10, 2026 at 10:30 UTC, according to Nexqual real-time market data.
PJP last closed at USD 110.44; the session ranged USD 110.97–112.05 on volume of 20,090 shares. Market capitalization is —, with a 52-week range of USD 78.77–112.05 (PCX). Source: Nexqual, June 10, 2026 at 10:30 UTC.
Key Statistics (as of June 10, 2026 at 10:30 UTC)
| Price | USD 112 |
|---|---|
| Change | ▲ 1.41% (up) |
| Previous Close | USD 110.44 |
| Open | USD 111.09 |
| Day Range | USD 110.97 – 112.05 |
| 52-Week Range | USD 78.77 – 112.05 |
| Volume | 20,090 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (PJP)
Nexqual's technical model rates PJP "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 10:30 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.25 (neutral) |
| vs SMA50 | Above (USD 105.98) |
| MACD | 1.06 (positive) |
Financial Health Score (PJP)
Nexqual rates PJP's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 10:30 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PBE | Invesco Biotechnology & Genome | USD 84.25 | ▲ 0.92% |
| IHE | iShares U.S. Pharmaceutical ETF | USD 93.79 | ▲ 1.19% |
| XPH | State Street SPDR S&P Pharmaceu | USD 58.29 | ▲ 2.19% |
| PBJ | Invesco Food & Beverage ETF | USD 47.53 | ▼ 0.69% |
| FBT | First Trust Amex Biotech Index | USD 226.09 | ▲ 1.5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 10:30 UTC. This page is informational and not investment advice.